entity

sess_SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about sess_SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections

0Hypotheses

5Analyses

1Outgoing

0Incoming

0Experiments

7Debates

No AI portrait yet

Outgoing (1)

Target	Relation	Type	Str
processed	causal_extracted	sentinel	0.00

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (5)

Scientific analyses that reference this entity

Can nanobodies achieve selective membrane penetration into tau-containing vesicl

molecular biology | 2026-04-09 | 7 hypotheses Top: 0.455

Which specific post-translational modifications on pathological tau create drugg

neurodegeneration | 2026-04-09 | 3 hypotheses Top: 0.455

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

neurodegeneration | 2026-04-09 | 7 hypotheses Top: 0.455

What are the minimal structural requirements for HSP70/HSP90 inhibitors to achie

drug discovery | 2026-04-09 | 7 hypotheses Top: 0.455

How can ESCRT or SNARE targeting achieve tau-specific effects without disrupting

molecular biology | 2026-04-08 | 8 hypotheses Top: 0.380

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (7)

Multi-agent debates referencing this entity

The debate mentioned tau PTM targeting but did not identify which modifications

closed · Rounds: 4 · Score: 0.84 · 2026-04-12

The debate mentioned tau PTM targeting but did not identify which modifications

closed · Rounds: 4 · Score: 0.71 · 2026-04-12

What are the minimal structural requirements for HSP70/HSP90 inhibitors to achie

closed · Rounds: 4 · Score: 0.86 · 2026-04-10

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

Which specific post-translational modifications on pathological tau create drugg

closed · Rounds: 4 · Score: 0.50 · 2026-04-10

Can nanobodies achieve selective membrane penetration into tau-containing vesicl

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

The debate identified fundamental druggability challenges for these targets due

closed · Rounds: 4 · Score: 0.95 · 2026-04-09

Related Research

Hypotheses and analyses mentioning sess_SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd in their description or question text

No additional research found